Delayed Recognition of Statin-Induced Immune-Mediated Necrotizing Myopathy in an Older Adult

Read full text Summarise with VIRAT
Authors: Daniela Barbosa, Eva Fernandes, Joana Carvalho Sousa, Ana Constante, Sofia Rodrigues Carvalho, Nuno Caetano Ribeiro da Silva Magalhães, Diana Cruz
Cited by: 0
References: 9

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Statins, widely used for cardiovascular prevention, may rarely induce immune-mediated necrotizing myopathy (IMNM), a severe and potentially disabling condition. We describe a 79-year-old woman with hypertension, dyslipidemia, and obesity who developed progressive proximal weakness and persistent creatine kinase (CPK) elevation after statin discontinuation. Infectious, neoplasms and systemic autoimmune causes were excluded. Strong anti-HMGCR antibody positivity, combined with magnetic resonance imaging (MRI) and electromyographic evidence of inflammatory necrosis, confirmed statin-associated IMNM. The patient improved with corticosteroids, intravenous immunoglobulin (IGIV), and methotrexate. This case highlights the importance of recognizing IMNM in statin users with unexplained weakness and sustained CPK elevation, as early immunosuppressive therapy can prevent long-term disability. This case highlights the importance of recognizing IMNM in statin users with unexplained weakness and sustained CPK elevation, as early immunosuppressive therapy can prevent long-term disability.

Fields of Study & Subjects

Inflammatory Myopathies and Dermatomyositis Peripheral Neuropathies and Disorders Myasthenia Gravis and Thymoma

Publication details

Journal / source
Brazilian Journal of Case Reports
Volume
6
Issue
1
Pages
bjcr172–bjcr172
Publication date
21 March 2026
Language
EN